MedTrace Logo

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

NCT05306184 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2026-04-21

No results posted yet for this study

Summary

Prospective observational cohort study to determine cost-effectiveness of ECT compared to medication in the treatment of major depressive disorder (MDD) in the Netherlands.

Conditions

  • Depressive Disorder, Major

Interventions

PROCEDURE

Electroconvulsive therapy (ECT)

ECT

Sponsors & Collaborators

  • GGZ inGeest

    collaborator OTHER

  • Canisius-Wilhelmina Hospital

    collaborator OTHER

  • UMC Utrecht

    collaborator OTHER

  • St. Antonius Hospital

    collaborator OTHER

  • Parnassia

    collaborator UNKNOWN

  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Philip van Eijndhoven, PhD, MD · Radboud University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-12-31
Completion
2026-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05306184 on ClinicalTrials.gov